Monday, June 22, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 526 of 1,261

  1. US 10166288

    Vaccines having an antigen and interleukin-21 as an adjuvant

    Inovio Pharmaceuticals, Inc. · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted

  2. US 10166277

    Vault immunotherapy

    THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted

  3. US 10166294

    Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same

    Serina Therapeutics, Inc. · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted

  4. US 10166271

    Methods for promoting hair growth

    The Regents of the University of California · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted

  5. US 10166219

    Formulations and methods of manufacturing formulations for use in colonic evacuation

    RedHill Biopharma Ltd. · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted

  6. US 10166243

    Optimizing mifepristone levels for cushing'S patients

    Corcept Therapeutics Incorporated · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted

  7. US 10166242

    Optimizing mifepristone levels for Cushing's patients

    Corcept Therapeutics Incorporated · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted

  8. US 10166244

    Targeting NCCA-ATP channel for organ protection following ischemic episode

    The United States of America as represented by the Department of Veteran Affairs · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted

  9. US 10165788

    Methods and compositions for improved digestion of milk oligosaccharides

    The Regents of the University of California · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted

  10. IL 240179

    Use of a monoclonal, chimeric, human antibody that binds il-5r in the manufacture of a medicament for reducing the numbers of blood basophils in a human subject

    BIOWA INC [US] · Granted Dec 31, 2018 · Expires Dec 26, 2038

    granted

  11. US 10160745

    Piperidine and azepine derivatives as prokineticin receptor modulators

    Takeda Pharmaceutical Company Limited · Granted Dec 25, 2018 · Expires Dec 20, 2038

    granted

  12. US 10160736

    1,3,4-oxadiazole and 1,3,4-thiadiazole derivatives as immunomodulators

    Aurigene Discovery Technologies Limited · Granted Dec 25, 2018 · Expires Dec 20, 2038

    granted

  13. US 10159703

    Traditional chinese medicine composition for relieving chronic pain and preparation method and use thereof

    INFINITUS (CHINA) COMPANY LTD. · Granted Dec 25, 2018 · Expires Dec 20, 2038

    granted

  14. US 10160802

    Anti-malarial compositions

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 25, 2018 · Expires Dec 20, 2038

    granted

  15. US 10160760

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Dec 25, 2018 · Expires Dec 20, 2038

    granted

  16. US 10159677

    4-OXO-3,4-dihydro-1,2,3-benzotriazine modulators of GPR139

    Takeda Pharmaceutical Company Limited · Granted Dec 25, 2018 · Expires Dec 20, 2038

    granted

  17. US 10160957

    Development of dengue virus vaccine components

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 25, 2018 · Expires Dec 20, 2038

    granted

  18. US 10160954

    Engineered physical alignment of stem cell-derived cardiomyocytes

    The Regents of the University of California · Granted Dec 25, 2018 · Expires Dec 20, 2038

    granted

  19. US 10160961

    Factor VII polypeptides that are modified and uses thereof

    Catalyst Biosciences, Inc. · Granted Dec 25, 2018 · Expires Dec 20, 2038

    granted

  20. US 10160962

    Purification of cystathionine beta-synthase

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 25, 2018 · Expires Dec 20, 2038

    granted

  21. US 10160795

    Neutralizing antibodies to Ebola virus glycoprotein and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 25, 2018 · Expires Dec 20, 2038

    granted

  22. US 10162933

    High resolution allele identification

    REGENERON PHARMACEUTICALS, INC. · Granted Dec 25, 2018 · Expires Dec 20, 2038

    granted

  23. US 10160753

    Indazole compounds as IRAK4 inhibitors

    Aurigene Discovery Technologies Limited · Granted Dec 25, 2018 · Expires Dec 20, 2038

    granted

  24. US 10160769

    Compositions comprising thienopyrimidine and thienopyridine compounds and methods of use thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Dec 25, 2018 · Expires Dec 20, 2038

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.